Skip to main content


What People With Asthma Need to Know About Face Masks and Coverings During the COVID-19 Pandemic

Update – Aug. 13, 2020 We updated this blog post to include information on types of face masks or coverings that aren't effective at preventing the spread of the new coronavirus. As we all return to work, school and public places, face coverings and masks have become essential tools in our fight against COVID-19 (the new coronavirus) . But wearing a face covering raises many questions for people with asthma . Why Do We Need to Wear Face Masks or Coverings During the COVID-19 Pandemic?

AAFA Appoints Melanie Carver Chief Mission Officer

The Asthma and Allergy Foundation of America (AAFA) is excited to announce Melanie Carver has been named Chief Mission Officer of the organization. As Chief Mission Officer, Carver will continue to lead AAFA’s programmatic work as a community-focused organization. Included in that community focus, she will oversee AAFA’s community outreach, marketing and communications, education, and asthma & allergy friendly® Certification Program relations. She will also continue to help provide...

Advocacy Update: Funding for Asthma Programs and Food Allergy Research, Protections for Students, and Action on Sesame Allergy

Great Strides in July 2020 for People With Asthma and Allergies AAFA has made great strides this month in advocating for policies that protect people with asthma and allergies. The House Energy and Commerce Committee passed the School-Based Allergies and Asthma Management Program Act (H.R. 2468) and the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act (H.R. 2117) . These have been top priority issues for our organization and we're excited for this progress! UPDATE...

Cleaning Your Hands With Soap Vs. Hand Sanitizer: What Is Best to Protect Yourself From COVID-19 and Other Illnesses?

Keeping your hands clean is one of the easiest ways to reduce the spread of the new coronavirus that causes COVID-19 . It can also help help protect you from flu, colds and other respiratory infections . It also helps prevent foodborne illnesses (such as salmonella) while cooking. One study shows people touch their faces on an average of 23 times an hour. 1 Your hands come in contact with many germs, and when you touch your face, you increase your chances of getting sick. Keeping them clean...

Coronavirus (COVID-19) Crisis: Some States Open Enrollment for Health Insurance

Update – July 20, 2020 We have updated this blog post to reflect which states have ended or extended their open enrollment periods. With the spread of the new coronavirus (COVID-19) , many uninsured people are concerned about medical costs if they get sick. Several states have opened up their health care exchanges for a special open enrollment period. Some states are also giving people who’ve lost their jobs the chance to enroll. If you need insurance, you can enroll in the following states:...

First Digital Quick-Relief Albuterol Inhaler Uses Technology to Aid in Asthma Management

Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. today announced the launch of ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder, the first and only digital rescue inhaler indicated in patients four years or older for the treatment or prevention of bronchospasm who have reversible obstructive airway disease, and for prevention of exercise-induced bronchospasm (EIB).

Ask the Allergist: What Is Considered a High Dose of Steroids for Asthma Treatment?

Information from AAFA’s Ask the Allergist is not a substitute for a consultation with a health care professional. Always talk with your own doctor before making changes to your asthma or allergy management plan. This question appeared in our spring/summer 2020 issue of freshAAIR Magazine, our FREE digital magazine featuring news and resources on asthma and allergies. Read the most recent issue. Question: When using oral steroids daily for the treatment of asthma, what is considered a “high...

Asthma and Allergy Research With You as an Equal Partner

The Asthma and Allergy Foundation of America (AAFA) conducts and promotes patient-centered research to help you. This means your beliefs, preferences and needs are at the center of our research. Your input drives our advocacy work, guides our education programs and supports our community. Recently, we’ve studied the following topics: Symptoms of anaphylaxis in infants and toddlers Eczema burdens and people’s experiences with treatments Impact of COVID-19 on people with asthma and allergy Air...

COVID-19 Impacts on People With Asthma and Allergies

Due to the coronavirus pandemic , families face uncertainty related to health, finances and overall well-being. The Asthma and Allergy Foundation of America (AAFA) surveyed 2,695 people to understand the impact of COVID-19 on asthma and allergy communities. The survey revealed the reach of the virus, how families are protecting themselves and the challenges families face specific to asthma and allergies. AAFA will use the results to target communication, education and advocacy efforts. Of...

Healthline Names AAFA Blog as One of the Best Blogs on Asthma for 2020

We are honored that the Asthma and Allergy Foundation of America’s blog has again been named one of the best asthma blogs by Healthline for 2020! Healthline is a health site with information on many health topics. We have received this honor since 2015 when we started our blog! Comment below to tell us what you want to see more of on our blog. We could not have received this honor without all of our supporters and members. Our blog will continue to bring you information about asthma and...

FDA Approves Dupixent® (Dupilumab) for Children Aged 6 to 11 Years With Moderate-to-Severe Atopic Dermatitis

The U.S. Food and Drug Administration (FDA) approved Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent is the only biologic medicine approved for this patient population.

Letter to the FDA: Require Food Manufacturers to Post Substitutions

On May 22, 2020, the Food and Drug Administration (FDA) relaxed labeling guidelines for food companies . This is a temporary measure because of food supply issues due to COVID-19 (the new coronavirus). The Asthma and Allergy Foundation of America (AAFA) met with the FDA to talk about how this will affect the food allergy community. After the meeting, we organized a joint letter with other food allergy advocacy organizations to send to the FDA. The letter addresses the FDA’s short-term food...